Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
A trial of discontinuation with close monitoring is reasonable in this group
Dosing schedules, side effects, and patient tolerability can vary, making individualized care essential
The magnitude of lipid change depends on several variables: baseline lipid levels, degree of weight loss achieved, concurrent statin use, and dietary patterns during treatment
MT-1 was first developed as a sunless tanning agent, as its ability to bind to melanocortin receptor 1 causes skin to produce more melanin, turning it darker
Persistent or severe side effects warrant immediate cessation and re-evaluation of the protocol and peptide source
How Mochi Health Compares to the Standard of Care The American Association of Clinical Endocrinology (AACE) 2023 obesity management algorithm recommends that patients with BMI 30 (or BMI 27 with at least one obesity-related comorbidity) be offered pharmacotherapy alongside lifestyle intervention, with prescriber follow-up at 4, 8, and 12 weeks after initiation, then every 3 months [13]
